December 14, 2024 02:35 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess
Five Pharma majors to collab for clinical trial of Molnupiravir drug

Five Pharma majors to collab for clinical trial of Molnupiravir drug

Jun 29, 2021, at 11:54 pm

Hyderabad/UNI: Five Indian pharmaceutical majors joined hands to hold the clinical trial of the investigational and oral anti-viral drug Molnupiravir that inhibits the replication of multiple RNA viruses, including SARS-CoV-2,  meant to treat mild COVID-19 outdoor patients in India.

IIT Kharagpur model shows SARS-CoV-2 alters lung cell metabolism, could help therapeutics

IIT Kharagpur model shows SARS-CoV-2 alters lung cell metabolism, could help therapeutics

Apr 15, 2021, at 02:36 am

Kharagpur/IBNS: A research model developed by IIT Kharagpur researchers predicting alteration in metabolic reaction rates of lung cells post SARS-CoV-2 infection is expected to lead to a better understanding of metabolic reprogramming and aid the development of better therapeutics to deal with the viral pandemics, according to the researchers.